- Home
- NVFY vs SABS Comparison
NVFY vs SABS Comparison
Compare NVFY & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- SABS
- Stock Information
- Founded
- NVFY 2003
- SABS 2014
- Country
- NVFY United States
- SABS United States
- Employees
- NVFY N/A
- SABS N/A
- Industry
- NVFY Home Furnishings
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- SABS Health Care
- Exchange
- NVFY Nasdaq
- SABS Nasdaq
- Market Cap
- NVFY 14.3M
- SABS 15.8M
- IPO Year
- NVFY N/A
- SABS N/A
- Fundamental
- Price
- NVFY $1.22
- SABS $1.81
- Analyst Decision
- NVFY
- SABS Strong Buy
- Analyst Count
- NVFY 0
- SABS 6
- Target Price
- NVFY N/A
- SABS $11.17
- AVG Volume (30 Days)
- NVFY 36.5K
- SABS 72.7K
- Earning Date
- NVFY 05-15-2025
- SABS 06-17-2025
- Dividend Yield
- NVFY N/A
- SABS N/A
- EPS Growth
- NVFY N/A
- SABS N/A
- EPS
- NVFY N/A
- SABS N/A
- Revenue
- NVFY $9,946,300.00
- SABS $377,835.00
- Revenue This Year
- NVFY N/A
- SABS N/A
- Revenue Next Year
- NVFY N/A
- SABS N/A
- P/E Ratio
- NVFY N/A
- SABS N/A
- Revenue Growth
- NVFY N/A
- SABS N/A
- 52 Week Low
- NVFY $0.39
- SABS $1.00
- 52 Week High
- NVFY $2.08
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- NVFY 55.19
- SABS 51.92
- Support Level
- NVFY $0.91
- SABS $1.76
- Resistance Level
- NVFY $1.22
- SABS $2.00
- Average True Range (ATR)
- NVFY 0.19
- SABS 0.15
- MACD
- NVFY -0.03
- SABS -0.01
- Stochastic Oscillator
- NVFY 40.79
- SABS 44.93
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.